2018 Wisconsin Genetics Exchange
The 2018 Wisconsin Genetics Exchange will provide participants with an opportunity for statewide collaboration and continued professional development. Sharing of knowledge and practices is an important way of increasing the competency of actioners in Wisconsin. Genetics education is one of the aims of the MCH block grant-funded Genetics Systems Integration initiative which is part of the network of programs supporting children and youth with special health care needs and their families. The audience will consist of genetic counselors, medical geneticists, laboratory personnel, and other healthcare providers that make up the genetics workforce.
As clinical genetics and genomic sequencing continues to advance and integrate into clinical medicine, a myriad of clinical and ethical questions are being raised and demand thoughtful responses. As genetic technology advances, thoughtful integration into clinical practice requires continued education on current practices, technologies, and testing options. These questions, such as which test results should be disclosed, and how might results impact patients and their families, have no easy answers, yet clinicians, researchers and the general public will need to know how to best respond to these inquiries.
Target Audience
This activity is intended for physicians, fellows/residents, physician assistants, nurses, genetic counselors, geneticists, lab technicians, and other allied health care professionals.
Learning Objectives
- Apply new knowledge and tools to their professional practice
- Discuss how evolving technology issues impact clinical genetics
- Describe how public health initiatives, including funding and public access to genomic information, changes how they practice.
8:00 | Registration (Light breakfast provided) |
8:45 | Welcome – Donald Basel, MD |
8:50 | Opening Remarks – Sharon Fleischfresser, MD |
9:00 | The New Role of Genetic Counseling in Precision Medicine – Raul Urrutia, MD ● Discuss how precision medicine is moving us to a data-driven healthcare system ● Identify the role of the genetic counselor as the champion of the patient and the clinician ● Describe overview of workflow that promotes integration, collaboration, and advancement of care |
9:45 | Molecular Modeling and the Next Frontiers of Genetics Interpretation – Michael Zimmermann, PhD ● Describe how annotation and informatics guide understanding of genomics data ● Identify the role of molecular modeling for generating novel information to interpret functional effects of genomic variation ● Describe how to combine molecular information with existing knowledge to establish mechanisms |
10:30 | Break |
10:45 | GSI Hub Collaborative Activities – Sara Zoran, MS, CGC ● Discuss regional collaborative efforts to improve access to genetics services for underserved populations |
10:55 | National Genetic Counselor Workforce Initiatives – Casey Reiser, MS, CGC ● Discuss strategies to increase genetic counselor workforce |
11:10 | Wisconsin Genetic Counselors Association (WIGCA) Update – Jenny Geurts, MS, CGC |
11:15 | Wisconsin Newborn Screening Program: What’s New? – Gary Kirk, MD, MPH, MHPE (Remote) ● Discuss current and future directions of the Wisconsin Newborn Screening Program |
11:30 | A Wisconsin Network for Rapid Genomic Diagnosis of Newborns: A Proposal – Stephen Meyn, MD, PhD ● Describe the cumulative incidence and clinical impact of rare genetic disorders in newborns ● Discuss the strengths and limitations of rapid genome-wide diagnostic testing in the newborn period ● Identify the challenges involved in implementing a statewide network for rapid sequencing of critically ill newborns |
12:10 | Lunch (provided) |
1:00 | Treatment of Neuromuscular Diseases – Matthew Harmelink, MD ● Describe current and upcoming treatments for 5q Spinal Muscular Atrophy ● Describe upcoming treatments for peripheral nerve diseases |
1:35 | Gene Therapies for Congenital Muscle Disease – Michael Lawlor – MD, PhD ● Describe the mechanism and pathology of X-Linked Myotubular Myopathy (MTM) and Duchenne Muscular Dystrophy (DMD) ● Describe current progress in translating adeno-associated virus gene therapy to the human clinical trial stage in MTM and DMD. |
2:00 | Diagnostic Dilemmas – Moderator: Laura Birkeland, MS, CGC ● Describe two examples of clinical diagnostic dilemmas in medical genetics and related disciplines ● Describe meaningful recommendations for possible further testing and/or evaluation |
2:55 | Closing Remarks – Donald Basel, MD |
3:00 | Adjourn |
Individuals who wish to receive credit must complete the evaluation form which will be sent to the email address provided at registration.
3:10-4:00 Wisconsin Genetic Counselors Association Business Meeting
All persons in control of content have NO relevant financial relationships to disclose.
Planning Committee:
Donald Basel, MD
Jennifer Geurts; MS, CGC
Anne Bradford-Harris, PhD, MPH
Alison Kirschner-LaPean, MS, CGC
Erin Syverson, MS, CGC
Raul Urruta, MD
LuAnn Weik MS, CGC
Sara Zoran, MS, CGC
Speakers:
Laura Birkeland, MS, CGC
Donald Basel, MD
Sharon Fleischfresser, MD
Jenny Geurts, MS, CGC
Matthew Harmelink, MD
Gary Kirk, MD, MPH, MHPE
Stephen Meyn, MD, PhD
Casey Reiser, MS, CGC
Raul Urrutia, MD
Michael Zimmermann, PhD
Sara Zoran, MS, CGC
Name | Company | Role |
Matthew Harmelink, MD (Speaker) | Biogen Sarepta PTC | Speaker Advisory Board Advisory Board |
Michael Lawlor – MD, PhD (Speaker) | Audentes Therapeutics Solid Biosciences Ichorion Therapeutics | Board Member Board Member Board Member
|
Stephen Meyn, MD, PhD (Speaker) | Gene42 | co-developer |
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 4.75 hours of participation for continuing education for allied health professionals.
Available Credit
- 4.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.75 Hours of ParticipationHours of Participation credit.